Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

about

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

Item

http://www.wikidata.org/entity/Q38648122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

@en

type

Item

label

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

@en

prefLabel

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

@en

P1476

Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situ.

@en

P2093

Brian J Czerniecki

http://www.w3.org/2001/XMLSchema#string

M Catherine Lee

http://www.w3.org/2001/XMLSchema#string

Nadia F Nocera

http://www.w3.org/2001/XMLSchema#string

P2860

CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful

Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

Early dissemination seeds metastasis in breast cancer.

Dendritic cell-based vaccines: barriers and opportunities

The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease.

A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.

HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.

Progressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restoration

HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer

P304

1459-1462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON-2017-0151

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28766964

http://www.w3.org/2001/XMLSchema#string